It’s important to let your advertisers, readers and funders know how great your online presence is. That’s why we send every winner and finalist the appropriate seal to display on their website, in their print publication and with any promotional material.
We help you let the world know that you have been honoured by expert judges in the field for your outstanding award-winning digital publishing presence.
News provided by Business Wire
New Season Starts Streaming October 30 on Disney+
Discover a Bounty of All-New Star Wars Products, Books, Comics and Digital Content Inspired by the Hit Lucasfilm Series
Pre-Orders on Select Items Begin Later Today
GLENDALE, Calif.--(BUSINESS WIRE)--Fans of the Disney+ original series “The Mandalorian” just received a new reason to look forward to Mondays. Disney and Lucasfilm today announced Mando Mondays, an all-new global consumer products, games and publishing program, kicking off on October 26, that will debut goods inspired by the series.
After premiering last fall and quickly taking the world by storm, “The Mandalorian” – which took home seven awards last week during the 2020 Primetime Emmy® Awards – will return for its highly anticipated second season Friday, October 30, streaming only on Disney+. The Mandalorian and the Child continue their journey, facing enemies and rallying allies as they make their way through the dangerous galaxy in the tumultuous era after the collapse of the Galactic Empire.
After fans experience the latest episode every Friday on Disney+, they can visit MandoMondays.com each Monday to see what new toys, collectibles, apparel, books, comics, digital content and more will be unveiled. Mando Mondays will run for nine weeks, culminating on December 21.
“When ‘The Mandalorian’ debuted last year on Disney+, the show became an instant phenomenon, with fans of all ages expressing excitement for products related to its iconic characters – particularly the Child,” said Kareem Daniel, president, Disney Consumer Products, Games and Publishing. “This fall, as the world continues to watch the narrative unfold, we will further bring this unique Star Wars story to life through a must-have selection of toys, books, comics, digital content, and more.”
To celebrate this announcement, select pre-orders for the first wave of Mando Mondays products will kick off today at 1:00 p.m. PDT / 4:00 p.m. EDT across top retailers globally, including shopDisney.com. Products available for pre-order today include the Hasbro Black Series Credit Collection, new Funko Pop! bobbleheads, the LEGO® Star Wars The Child construction set and much more, all viewable now at MandoMondays.com.
The countdown starts now! For more details, visit MandoMondays.com and follow the conversation on social using #MandoMondays.
About Disney Consumer Products, Games and Publishing
Disney Consumer Products, Games and Publishing (CPGP) brings the magic of The Walt Disney Company’s brands and franchises—including Disney, Pixar, Marvel, Star Wars, National Geographic, and more—into the daily lives of families and fans around the world through products and experiences across more than 100 retail categories from toys and t-shirts to apps, books, video games, and more. A division of the Disney Parks, Experiences and Products segment, CPGP’s global operations include: the world’s largest licensing business, one of the biggest children’s publishing brands, a leading licensor of interactive games across platforms, Disney store locations globally, and the shopDisney e-commerce platform.
About Lucasfilm Ltd.
Lucasfilm Ltd., a wholly-owned subsidiary of The Walt Disney Company, is a global leader in film, television and digital entertainment. In addition to its feature film and series production, the company's offerings include cutting-edge visual effects and audio post-production, digital animation, immersive storytelling, and the management of the global merchandising activities for its entertainment properties including the legendary STAR WARS and INDIANA JONES franchises. Lucasfilm Ltd. is headquartered in northern California.
Lucasfilm, the Lucasfilm logo, STAR WARS and related properties are trademarks and/or copyrights, in the United States and other countries, of Lucasfilm Ltd. and/or its affiliates. © & TM Lucasfilm Ltd.
Disney+ is the dedicated streaming home for movies and shows from Disney, Pixar, Marvel, Star Wars, National Geographic, and more. As part of Disney’s Direct-to-Consumer and International (DTCI) segment, Disney+ is available on most internet-connected devices and offers commercial-free programming with a variety of original feature-length films, documentaries, live-action and animated series and short-form content. Alongside unprecedented access to Disney’s incredible library of film and television entertainment, the service is also the exclusive streaming home for the latest releases from The Walt Disney Studios. Disney+ is available as part of a bundle offer that gives subscribers access to Disney+, Hulu (ad-supported), and ESPN+. Visit DisneyPlus.com to subscribe and/or learn more about the service.
LEGO and the LEGO logo are trademarks of the LEGO Group. ©2020 The LEGO Group.
Disney Consumer Products, Games and Publishing
NEW YORK--(BUSINESS WIRE)--Insider Intelligence today announces that Steve Dodman is joining the company as senior vice president of sales.
At Insider Intelligence, Dodman will lead the global sales organization, providing strategic guidance, leadership, and direction. As a member of the senior executive team, Dodman will also help to set the company's strategy moving forward and deliver against its ambitious financial and strategic goals.
“We're excited to have Steve join our senior team during this period of significant growth and innovation at Insider Intelligence,” said Barbara Peng, president of the company. “Steve will be a tremendous resource for us as we continue to envision new solutions that address real business challenges faced by the world's largest and most innovative corporations.”
Dodman has over 20 years of sales and sales leadership experience with deep domain expertise in the subscription research, advisory and consulting sectors. He is a data-driven, operationally oriented leader who knows how to scale sales teams and execute go-to-market strategies to cultivate high-growth environments. Dodman most recently served as Chief Sales Officer for Richardson Sales Performance, a global sales performance improvement company.
Said Dodman about his new position: "I'm thrilled to join the talented team at Insider Intelligence. The acceleration of digital transformation offers outstanding opportunities for companies to innovate, drive top-line growth, and improve profitability. Insider Intelligence is a powerful resource that provides business leaders with the data and insights needed to make crisp decisions and seize on the promise of the digital decade that lies ahead."
Dodman will report to Peng, and be based at the company’s global headquarters in New York City.
About Insider Intelligence
Formed in 2020 from the combination of eMarketer and Business Insider Intelligence (BII), Insider Intelligence aims to be the world’s leading research service focused on digital transformation. Insider Intelligence helps thousands of global industry leaders to understand the critical trends and developments that are rapidly transforming their industries. Each year, Insider Intelligence produces nearly 300 reports, 7,000 charts, 1,500 newsletters, and 200 forecasts across the Advertising & Marketing, Consumer Demographics, Social Media, Video, Mobile, E-Commerce & Retail, Telecoms & Technology, Financial Services, and Digital Health industries. Insider Intelligence is owned by Berlin-based Axel Springer S.E.
- Patients Retained Function Longer on AMX0035 Versus Placebo; Study Achieved Its Primary Outcome of a Difference on the Revised ALS Functional Rating Scale
- AMX0035 is the First Investigational Therapy to Demonstrate Statistically Significant Benefit on this Prespecified Primary Outcome in People with ALS Since Approved Therapy Edaravone
- AMX0035 Showed Numerical Benefits on Secondary Outcomes Including Measures of Muscle Strength, Breathing, and Hospitalizations
- AMX0035 Was Generally Well Tolerated with Similar Rates of Adverse Events Recorded in the AMX0035 and Placebo Groups
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases, today announced the publication of results from the pivotal CENTAUR trial evaluating AMX0035 – an investigational neuroprotective therapy designed to reduce the death and dysfunction of motor neurons – in people with ALS in the New England Journal of Medicine (NEJM).
“CENTAUR met its prespecified primary outcome, showing a clinically meaningful and statistically significant treatment benefit on the Revised ALS Functional Rating Scale (ALSFRS-R), the most commonly used scale in clinics worldwide to measure function in ALS,” said Sabrina Paganoni, M.D., Ph.D., principal investigator of the CENTAUR trial, investigator at the Sean M. Healey & AMG Center for ALS at Mass General and Assistant Professor of PM&R at Harvard Medical School and Spaulding Rehabilitation Hospital. “These results represent a major milestone for the ALS community, and I am thrilled about the promise of this therapy for people with ALS.”
The CENTAUR trial of 137 individuals with ALS was conducted across 25 top medical centers in the U.S. through the Northeast ALS (NEALS) consortium. It demonstrated that treatment with AMX0035 was well tolerated and decreased the rate of decline in the ALSFRS-R compared to placebo in people with ALS.
“The data published today in the New England Journal of Medicine show that AMX0035 demonstrated a clinically meaningful benefit and a favorable safety profile for people living with ALS. This development is a breakthrough for the ALS community and we are working collaboratively and expeditiously with agencies worldwide to bring this potential new treatment option forward,” said Josh Cohen, Co-CEO, Chairman and Co-Founder at Amylyx.
“The data published today makes a clear and compelling case that AMX0035 should be made available to people with ALS as soon as possible,” said Calaneet Balas, President and CEO of The ALS Association. “We look forward to working with Amylyx, the FDA, and the entire community to help make that happen. We are grateful to all the Ice Bucket Challenge donors whose contributions helped make this trial possible.”
After 24 weeks, patients treated with AMX0035 scored on average 2.32 points higher on the ALSFRS-R than the placebo group (p=0.03) using the study’s primary prespecified analysis. A change from baseline analysis was also conducted and indicated that the AMX0035 group scored 2.92 points higher at the end of 24 week follow up (p=0.01).
- The ALSFRS-R is a 48-point questionnaire measuring daily functions such as the ability to walk, dress independently, self-feed, speak and breathe.
- Just a 1-2 point change in the ALSFRS-R score can indicate a significant reduction in a patient’s ability to function independently. The ALSFRS-R measures many different daily functions so point differences can manifest differently in different patients. Some examples of a two point change on this scale include the difference between an individual eating successfully with some difficulty vs needing a feeding tube, or walking with assistance versus not walking at all.
In line with the primary outcome, patients on AMX0035 also showed numerical benefits on secondary outcomes including measures of muscle strength, breathing and hospitalization frequency, although the study was not powered for secondary outcomes.
- Progression in lung function (percent predicted slow vital capacity) was numerically slower in patients taking AMX0035 (Least Squares Difference=5.11 points, p=0.08).
- Participants in the AMX0035 group were hospitalized numerically less often (Hazard Ratio = 0.54, p=0.09).
- Rate of decline in overall muscle strength (percent predicted ATLIS) was numerically slower in patients taking AMX0035 (Least Squares Difference=2.82 points, p=0.12). The effect of AMX0035 on progression was nominally statistically significant for the upper limbs measurements (Least Squares Difference=4.27 points, p=0.04).
- Nearly all participants (46 out of 48 patients in placebo (96%) vs 86 out of 89 patients in the AMX0035 group (97%)) reported one or more treatment-emergent adverse events (TEAEs) during the trial. Most were nonserious, did not lead to modification or interruption of study drug dosing, and were not considered related to the study.
- Overall, safety was comparable between the groups, with fewer serious adverse events in the active group as compared to the placebo group (9 out of 48 patients (19%) in placebo vs 11 out of 89 patients (12%) in the AMX0035 group).
- GI adverse events, which were generally characterized as mild by investigators, occurred more frequently in the active group in the first 3 weeks of the trial (28.1% vs 12.5% placebo) and returned to levels comparable to placebo thereafter.
Most CENTAUR participants (77%) were receiving an approved ALS therapy (riluzole, edaravone, or both) during and/or before trial entry. Sensitivity analyses accounting for the duration of treatment under riluzole, edaravone, or both confirmed that the treatment effect of AMX0035 was independent of background approved ALS therapies.
CENTAUR was the recipient of the ALS ACT grant, and is supported by The ALS Association, ALS Finding a Cure, a program of The Leandro P. Rizzuto Foundation, the Northeast ALS Consortium, Healey Center for ALS at Mass General, and was funded in part by the ALS Ice Bucket Challenge.
“I am so proud of the ALS community efforts that made this milestone possible,” said Dr. Merit Cudkowicz, M.D., Chief Medical Officer from ALS Finding a Cure®, Director of the Sean M. Healey & AMG Center for ALS, Chief of Neurology at Mass General, and the Julianne Dorn Professor of Neurology at Harvard Medical School. “The CENTAUR study was designed and run through NEALS, was supported by a partnership between The ALS Association and ALS Finding a Cure, and is a phenomenal example of what can happen when a community works closely together to accelerate ALS progress.”
AMX0035 Long-Term Survival and Extension Data, Future Plans
Participants who completed CENTAUR were given the option after the trial to enroll in an open-label extension study and receive AMX0035 long-term. 92% of eligible CENTAUR participants elected to enroll in the extension study. Interim data from the ongoing open-label extension study are being submitted to a peer-reviewed journal shortly and will be published in the coming months.
Long-term survival analysis for the patients in the AMX0035 and placebo groups has been conducted as well. These data will be submitted to a peer-reviewed journal in the near future.
“We are deeply grateful to all of the CENTAUR participants and our partners who have helped and continue to help develop this important therapy for those living with ALS,” said Justin Klee, Co-CEO and Co-Founder of Amylyx. “We also look forward in the coming months to sharing results from the CENTAUR open-label extension study and the long-term survival analysis, and we will continue to keep the community closely informed on next steps.”
CENTAUR was a 24-week, randomized, double-blind, placebo-controlled Phase 2/3 clinical trial that evaluated the safety and tolerability of AMX0035 and assessed the drug’s impact on disease progression as measured by the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) when compared to placebo. The trial also assessed the effects of AMX0035 on other measures that are critical to people with ALS, including muscle strength, lung vital capacity, and biomarkers of neuronal degeneration.
CENTAUR enrolled patients 18-80 years old with definite ALS and within 18 months of symptom onset. The trial did not restrict patients from receiving edaravone or riluzole. More information on the CENTAUR trial can be found at https://amylyx.com/trials/ or www.clinicaltrials.gov, NCT03127514.
About Amyotrophic Lateral Sclerosis (ALS)
ALS is a relentlessly progressive and fatal neurodegenerative disorder caused by motor neuron death in the brain and spinal cord. Motor neuron loss in ALS leads to deteriorating muscle function, the inability to move and speak, respiratory paralysis, and eventually death. The vast majority of patients with ALS (>90%) have sporadic disease, showing no clear family history. Approximately 6000 people are diagnosed with ALS in the United States every year with an approximately similar number of deaths every year.
AMX0035 is an investigational neuroprotective therapy designed to reduce neuronal death and dysfunction. AMX0035 targets endoplasmic reticulum and mitochondrial dependent neuronal degeneration pathways in ALS and other neurodegenerative diseases.
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is a pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases. For more information, visit www.amylyx.com and follow us on LinkedIn and Twitter.
About The ALS Association
The ALS Association is the largest philanthropic funder of ALS research in the world. The Association funds global research collaborations, provides assistance for people with ALS and their families through its nationwide network of chapters and certified clinical care centers, and advocates for better public policies for people with ALS. The ALS Association builds hope and enhances quality of life while urgently searching for new treatments and a cure. For more information about The ALS Association, visit our website at www.alsa.org.
About ALS Finding a Cure
ALS Finding a Cure® is a research organization dedicated to being a game changer in discovering a cure for this fatal disease. Founded in 2014 by noted philanthropist and Conair Founder and Chairman, Leandro (Lee) Rizzuto, as a tribute to Christie Rizzuto, Lee’s daughter-in-law who was diagnosed with ALS in 2009 at the age of 41, and under the joint leadership of Denis Rizzuto and Peter N. Foss, ALS Finding a Cure® is focused on identifying the gaps in the scientific understanding of ALS that are preventing the development of a cure. The organization, a program of The Leandro P. Rizzuto Foundation, collaborates with a wide range of companies, ALS organizations, other disease non-profits, and ALS patients and families to ensure research efforts are non-duplicative, synergistic, and focused on the ultimate goal: getting to a cure. For more information about ALS Finding a Cure®, visit www.alsfindingacure.org.
About the Northeast ALS Consortium
The Northeast ALS Consortium (NEALS) is an international, independent, non-profit group of over 130 research sites around the world who collaboratively conduct clinical research in Amyotrophic Lateral Sclerosis (ALS) and other motor neuron diseases. The mission of NEALS is to translate scientific advances into new treatments for people with ALS and motor neuron disease as rapidly as possible. The NEALS network is governed by an Executive Committee and the Consortium research activities are advised by an experienced Scientific Advisory Board. Each Leadership team member brings a depth of experience and a unique perspective to the governance of NEALS. Through this leadership, active oversight is provided for ongoing operations along with new approaches to trial design evaluated and implemented.
Seasoned research vet joins company from Shoptalk, where she oversaw research and content
NEW YORK--(BUSINESS WIRE)--Insider Intelligence today announces that Zia Daniell Wigder is joining the company as senior vice president of content. Wigder, who recently left her position as chief global content officer at Shoptalk, will oversee research and content at Insider Intelligence, the recently named company composed of eMarketer and Business Insider Intelligence.
Wigder will manage a growing team of experienced researchers, analysts, forecasters, and editors – a group that has added 30 new members in 2020 alone. She will build upon the company’s renowned research in existing coverage areas, including advertising, marketing, media, and retail ecommerce, and lead further development of the financial services and digital health verticals. In addition, Wigder will work closely with eMarketer chief evangelist and co-founder Geoff Ramsey to spotlight the team’s work product to clients and the broader market.
“We couldn’t be happier that Zia is joining our growing team,” said Barbara Peng, president of Insider Intelligence. “Zia has the ideal background and experience to help us continue to make Insider Intelligence a must-read for any company looking to capitalize on the rapid-fire digital transformation impacting all industries.”
Wigder has more than 20 years of research and management experience. At Shoptalk, the world’s leading conference for retail and ecommerce, Wigder oversaw research and content. Wigder helped grow the company from a four-person startup into the fastest-growing retail conference in the world. She led the launch of the company’s original content division, which offers research on transformation in the retail sector based on data, case studies, and analysis.
Prior to Shoptalk, Wigder was vice president and research director at Forrester Research, where she managed a team of analysts covering commerce technologies, payments, and globalization.
"I'm thrilled to be joining Insider Intelligence and to be working with such a phenomenal team. Digital transformation has never been more critical to businesses, and both eMarketer and Business Insider Intelligence are at the forefront of helping companies make this transition. I look forward to bringing my broad experience – from venture-backed startups to established research companies – to this exciting new role."
Wigder will report to Peng and be based at the company’s world headquarters in New York City.
About Insider Intelligence
Formed in 2020 from the combination of eMarketer and Business Insider Intelligence (BII), Insider Intelligence aims to be the world’s leading research service focused on digital transformation. Insider Intelligence helps thousands of global industry leaders to better understand and plan for the critical trends and developments that are rapidly transforming their industries. Each year, Insider Intelligence produces nearly 300 reports, 7,000 charts, 1,500 newsletters, and 200 forecasts across a growing number of subjects including advertising & marketing, consumer demographics, social media, video, mobile, e-commerce & retail, telecoms & technology, financial services, and digital health industries. Insider Intelligence is owned by Berlin-based Axel Springer S.E.
Acquisition brings more than 400 labs and course materials onto Top Hat’s proven active learning courseware platform
Educators who adopt these titles on Top Hat’s all-in-one teaching platform have the flexibility to deliver engaging courses and motivate their students in any teaching environment, whether online or in-person, synchronous or asynchronous, at a time of great uncertainty on college campuses brought on by COVID-19
Following the recent acquisition of Nelson’s Canadian higher ed textbook business, Top Hat is bringing traditional publishers into the digital age
Top Hat’s platform enables educators to bring active learning to life for students inside and outside the classroom, with tools to live-stream lectures, present and edit slides, record lectures for later viewing, host live chats, poll and quiz students during class, assign homework, and deliver formative and summative assessments
More than 3 million students are enrolled in courses using Top Hat at 750 of the top 1,000 higher ed institutions in North America
TORONTO--(BUSINESS WIRE)--#collegeaffordability--Top Hat, the leading active learning platform for higher education, has acquired bluedoor, an independent press that specializes in educational content for the sciences in higher education. Details of the transaction were not disclosed. The acquisition includes more than 400 labs and course materials used by more than 500 authors. These materials are being converted into digital courseware on Top Hat’s platform and infused with interactive elements, enabling educators to bring active learning to life in both virtual and in-person classrooms.
bluedoor is a leading publisher of high-quality and flexible publications for science disciplines, and its content is used at more than 400 institutions in the United States. By converting bluedoor’s print-only content into interactive digital courseware, Top Hat is ensuring that educators who adopt these titles will now be able to engage and motivate students in any teaching environment, whether online or in-person, synchronous or asynchronous, at a time of great uncertainty in higher education brought on by the COVID-19 pandemic.
“bluedoor has a stellar reputation as an expert in educational content for the sciences,” said Mike Silagadze, founder and CEO, Top Hat. “Our partnership has evolved into a perfect fit for bluedoor to join Top Hat and strengthen our market position in the science disciplines. We are excited to work as one team to empower educators with the tools and content they need to easily and effectively encourage and support student outcomes.”
"At bluedoor, our focus has always been on empowering educators with flexible high-quality content," said Jon Earl, CEO, bluedoor. "By joining Top Hat and transforming our content into interactive digital courseware on its all-in-one platform, we can enable more educators to deliver their courses effectively and bring active learning to life for their students."
“By migrating my bluedoor lab manual onto Top Hat’s all-in-one learning platform, I’ve been able to create a fully interactive version that engages students both inside and outside the lab, with videos, GIFs, and assessments that provide in-depth feedback on correct and incorrect answers,” said Derek Weber, Professor Biology and Microbiology at Raritan Valley Community College, and author of Focusing on Health: Laboratory Exercises in Microbiology. “This instant feedback informs students of their strengths and weaknesses in real time, and enables instructors to identify and focus on those concepts that are most challenging to students. This feature is especially useful in an online or hybrid environment.”
As Higher Education Moves Online, Every Traditional Publisher Needs a Digital Distribution Strategy
In February, 2020, Top Hat announced it raised $55M USD in Series D financing to drive the shift from traditional textbooks to digital interactive course materials. The company is working with print publishers like Fountainhead Press to transform their print-only content into interactive digital courseware. At the same time, Top Hat is scaling its ability to empower professors with the technology and support to author, adopt, curate, and adapt course materials to create personalized and responsive learning experiences for students.
Prior to the acquisition of bluedoor, Top Hat acquired the Canadian domestic higher ed textbook business from Nelson, Canada’s largest educational publisher, to expand its broad portfolio of best-in-class content delivered through Top Hat’s active learning platform. The acquisition transformed the Canadian higher education publishing landscape and positioned Top Hat as a leading player in the industry.
“The COVID-19 crisis has laid bare the urgent need for a substantial overhaul of the traditional textbook industry,” said Silagadze. “Prior to the pandemic, we were already seeing the digital transformation of educational content. The events of the last few months have drastically accelerated that shift to help students overcome heightened challenges associated with the cost, accessibility, and relevance of print textbooks. And once the crisis has ended, both educators and students are not likely to forget the improved learning experience offered by interactive digital content. Every traditional publisher needs a digital distribution strategy—Top Hat makes that possible, with the added benefit of a proven active learning platform designed to improve student outcomes.”
Top Hat’s Active Learning Platform Enables Educators to Deliver Engaging and Effective Learning Experiences in the Fall and Beyond
Top Hat is the only all-in-one courseware platform that enables active learning—a proven student-centred teaching pedagogy that promotes deep understanding, critical thinking, and subject mastery—by encouraging students to engage with the content before, during, and after class, in both in-person and online courses. As the complete solution for any teaching scenario, Top Hat offers tools for in-person as well as synchronous and asynchronous online learning, while creating active engagement and connections with students inside and outside virtual class meetings.
To learn more about Top Hat:
About Top Hat
Top Hat is the only all-in-one courseware platform that enables active learning—a proven student-centred teaching pedagogy that promotes deep understanding, critical thinking, and subject mastery—with interactive content, tools, and activities. Millions of students at 750 leading North American colleges and universities use Top Hat to teach and engage with students before, during, and after class, in both in-person and online education.
Dianna Lai Read
Delivering national and team multimedia content across all SI platforms
The Hockey News’ team of award-winning journalists provides fans comprehensive coverage with breaking news, exclusive storytelling, insights, commentary, photos, videos, and podcasts.
"After 73 years in continuous print as the global source of hockey coverage, The Hockey News begins a new era as Sports Illustrated’s exclusive content partner, operating on Maven’s digital publishing platform,” says W. Graeme Roustan, chairman, owner and publisher of Roustan Media, which owns The Hockey News.
The Hockey News will continue to publish its own magazine, and the digital destination is now co-branded within SI.com, as the exclusive source of Hockey content for SI.com. The Hockey News’ premiere journalists will continue to produce award-winning national and local team-focused content they’re known the world over for and will now gain worldwide distribution through Sports Illustrated and Maven’s combined 150 million monthly users.
“SI’s partnership strategy is consistent with Maven’s focus, to partner with the most authentic and respected content leaders in each field and The Hockey News fits that description perfectly,” said SI CEO, Ross Levinsohn. “From award-winning journalists covering teams like Alabama and the Dallas Cowboys, to empowering the top experts in sports categories such as Fantasy and the NFL, Sports Illustrated combines its rich history of trusted storytelling and best in class journalists with best in class partners. The Hockey News brings an authentic voice, trusted storytelling and real time coverage to create a dynamic experience for sports fans.”
Graeme added: “This partnership brings together the best of hockey and sports for an all-around, multi-dimensional experience for hockey fans. All of us at The Hockey News are excited to provide multimedia hockey content to our millions of readers around the world."
“This partnership offers exclusive depth and breadth of hockey coverage to Sports Illustrated, providing strong, unbiased, timely and noteworthy news to our millions of readers around the world,” said Sports Illustrated Co-Editor-in-Chief Ryan Hunt.
The Hockey News is the newest member of Maven’s premium coalition of over 300 independent media brands. “Best in class” partners, such as Jim Cramer and TheStreet, History.com, Biography, Yoga Journal, Ski Magazine, Sports Illustrated, Glam, Maxim and top sports journalists around the world operate on Maven’s digital advertising, distribution and publishing platform.
About Sports Illustrated
Sports Illustrated is an award-winning media enterprise and cultural touchstone that captures moments in sports and turns them into history. Offering the most relevant and innovative content in real-time, SI is the authoritative voice of the sports world and the source that connects audiences to athletes and teams across every touchpoint spanning entertainment, editorial, and digital platforms to live events and brand extensions.
About The Hockey News
The Hockey News was founded by Ken McKenzie and Will Cote in 1947 and was later owned and sold in 2014 by Transcontinental Media to Quebecor. In 2018 W. Graeme Roustan formed Roustan Media and acquired The Hockey News from Quebecor.
Its Toronto based team of editors and network of reporters wherever hockey is played have been producing the very best publication of hockey industry content for the past 73 years.
Maven (maven.io) is a coalition of Mavens, from individual thought-leaders to world-leading independent publishers, operating on a shared digital publishing, monetization and distribution platform, unified under a single media brand. Sports Illustrated is operated by Maven as part of its coalition. Based in Seattle, Maven is publicly traded under the ticker symbol MVEN.
Media Inquiries: Greg Witter, Press@maven.io
TORONTO--(BUSINESS WIRE)--Visitors to the Toronto Sun website will notice more of what they love about the Sun, but amped up with better performance on every platform. The new torontosun.com builds on the momentum of relaunched news websites across Postmedia brands. Between now and the end of August, all of Postmedia’s tabloid newspapers will feature all new upgrades including faster load times, easier navigation and more value for advertisers.
“This new look reflects the Sun sensibility – irreverent, bold and brassy and now with an overall better user experience,” said Adrienne Batra, Editor in Chief, Toronto Sun. “From in-depth local news stories and hard hitting columnists to entertainment, politics, comprehensive sports coverage and more, the Toronto Sun has it covered – and on every platform that our readers want it.”
Toronto Sun is the first of Postmedia’s tabloid brands to launch a new website. Redesigned websites will roll out for Calgary Sun, Edmonton Sun, Ottawa Sun, Winnipeg Sun and Vancouver’s The Province between now and the end of August.
New features of torontosun.com
Faster Load Time
- According to Google PageSpeed Insights, the new site is up to 68 per cent faster to load on mobile devices, exceeding the best-in-class standard for performance.
- The redesign delivers an uninterrupted scrolling experience.
- More white space and less clutter make it easier to browse.
- Curated index and category pages spotlight the newest, most relevant stories.
- It’s easier to find the best videos and related playlists.
- The new site offers improved accessibility including a primary navigation menu that can be used with or without a mouse.
- Fully responsive on desktop, tablet and mobile devices.
- Discoverability widgets help users find new content on the site or across the network
- Comments are now cross-device compatible and let users leave a comment, get email notifications and follow or unfollow other commenters.
- Additional ad slots on home page and long-form content
- Improved performance due to viewability
- Rich Interscroller
The initiative is being supported by an integrated advertising campaign produced in-house by Postmedia’s marketing team.
About Toronto Sun
Toronto Sun is a division of Postmedia Network Inc., a wholly owned subsidiary of Postmedia Network Canada Corp. (TSX:PNC.A, PNC.B), a Canadian newsmedia company representing more than 125 brands across multiple print, online, and mobile platforms. Award-winning journalists and innovative product development teams bring engaging content to millions of people every week whenever and wherever they want it. This exceptional content, reach and scope offers advertisers and marketers compelling solutions to effectively reach target audiences. For more information, visit www.postmedia.com.
Vice President, Communications
SAN DIEGO--(BUSINESS WIRE)--Diversified Nano Solutions Corporation (DNSC) is pleased to announce availability of the Typhoon C20590 MX MICR (“Typhoon”), the world’s lowest cost 100 ppm, cut sheet, All-In-One inkjet system for general purpose, checks, and security applications. The system combines highest performance in its class with exceptionally low cost of ownership. It is available in 2 configurations: a) 4 color CMY-MICR and b) with 2 separate MICR and Black ink channels, plus 2 additional channels for any combination of spot color, invisible fluorescent (Red, Green, Yellow, Blue) and/or IR inks (780-1070nm). INKcrypt® DNA biomarkers for security and document authentication are tailored for each customer, are brand specific and can be added to all inks and print channels.
The Typhoon provides five separate paper input trays with a total capacity of up to 5,350-sheets, all within the footprint of a medium-size workgroup printer/copier. Dynamic switching of paper tray source for multi-substrate jobs is possible using optional PageDeck™ Workflow software. The Typhoon supports PC/MAC as well as most legacy platforms and PCL 5, PCL 6, PDF and PostScript®. It also works with most ANSI X9 compliant check creation solutions, enterprise workflow applications, direct mail, payroll, production jobs and data streams.
The system handles a wide variety of paper sizes, substrates and high-volume paper handling accessories. High Resolution Piezo Line Head Technology ensures vivid, full color, high quality prints at 600 x 2400dpi.
The Typhoon C20590 MX ALL-IN-ONE MICR INKJET is ideally suited for productivity expansion and replacement of less efficient or outdated alternatives. It covers most output applications from general print jobs, mailings, checks, booklets, posters and security documents for business workgroups, financial institutions and print shops, supporting work loads of up to 1.5 Million impressions per month. Contact DNSC for pricing and availability.
Based in San Diego, California, with manufacturing facilities in the US and Europe, DNSC specializes in developing and manufacturing digital inks, nano materials and fluids for high-resolution, high-performance digital inkjet printing. DNSC provides unique ink development services, research and turn-key ink supply and fulfillment solutions world-wide. DNSC has developed an extensive product line under the x-nano™ brand, providing a range of solutions including high quality, low cost dye inks (Value-Series), pigment inks (Elite Series), special ultra-fast dry inks (S-Series), Magnetic MICR inks (K-Series), invisible fluorescent color (RGB) inks, Infrared-absorbing inks (I-Series), and special inks for food grade, textile and special effect applications (F-, T-, and X-Series). The company’s digital inks target dot-on-demand inkjet applications based on thermal and piezo print heads using aqueous, oil, energy curable (UV/LED) and eco-solvent based inks.
With the introduction of the Typhoon C20590 MX, DNSC adds a combined general-purpose, MICR, and special effect printing solution to its solution portfolio that bridges the price and performance gap between desktop/workgroup office printers and high-speed production systems. Typhoon maintenance and service is backed by a world leading inkjet system manufacturer, as well as third party/OEM service networks throughout the US.
© 2020 Diversified Nano Solutions Corporation. All rights reserved. All trademarks and company names are the property of their respective owners.